OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
Markus Hoffmann, Lu Zhang, Nadine Krüger, et al.
Cell Reports (2021) Vol. 35, Iss. 3, pp. 109017-109017
Open Access | Times Cited: 80
Markus Hoffmann, Lu Zhang, Nadine Krüger, et al.
Cell Reports (2021) Vol. 35, Iss. 3, pp. 109017-109017
Open Access | Times Cited: 80
Showing 51-75 of 80 citing articles:
Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020
Edmilson Ferreira de Oliveira-Filho, Otávio Carvalho, Ianei de Oliveira Carneiro, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Edmilson Ferreira de Oliveira-Filho, Otávio Carvalho, Ianei de Oliveira Carneiro, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
One-Year Surveillance of SARS-CoV-2 Exposure in Stray Cats and Kennel Dogs from Northeastern Italy
Laura Bellinati, Mery Campalto, Elisa Mazzotta, et al.
Microorganisms (2022) Vol. 11, Iss. 1, pp. 110-110
Open Access | Times Cited: 10
Laura Bellinati, Mery Campalto, Elisa Mazzotta, et al.
Microorganisms (2022) Vol. 11, Iss. 1, pp. 110-110
Open Access | Times Cited: 10
SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations
Gila Lustig, Yashica Ganga, Hylton Rodel, et al.
Virus Evolution (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Gila Lustig, Yashica Ganga, Hylton Rodel, et al.
Virus Evolution (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 5
The basis of mink susceptibility to SARS-CoV-2 infection
Avishak Barua, Natalia Grot, Andrzej Pławski
Journal of Applied Genetics (2022) Vol. 63, Iss. 3, pp. 543-555
Open Access | Times Cited: 9
Avishak Barua, Natalia Grot, Andrzej Pławski
Journal of Applied Genetics (2022) Vol. 63, Iss. 3, pp. 543-555
Open Access | Times Cited: 9
An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV
Haili Zhang, Hongli Jin, Feihu Yan, et al.
Virologica Sinica (2022) Vol. 38, Iss. 2, pp. 244-256
Open Access | Times Cited: 9
Haili Zhang, Hongli Jin, Feihu Yan, et al.
Virologica Sinica (2022) Vol. 38, Iss. 2, pp. 244-256
Open Access | Times Cited: 9
Vaccination of susceptible animals against SARS-CoV-2
Bin Xiang, Liang Yu, Zaijiao Ye, et al.
Journal of Infection (2022) Vol. 84, Iss. 5, pp. e48-e49
Open Access | Times Cited: 8
Bin Xiang, Liang Yu, Zaijiao Ye, et al.
Journal of Infection (2022) Vol. 84, Iss. 5, pp. e48-e49
Open Access | Times Cited: 8
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14057-14057
Open Access | Times Cited: 8
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14057-14057
Open Access | Times Cited: 8
Challenges and opportunities of molecular epidemiology: using omics to address complex One Health issues in tropical settings
Feven Tigistu‐Sahle, Zelalem Mekuria, Abhay R. Satoskar, et al.
Frontiers in Tropical Diseases (2023) Vol. 4
Open Access | Times Cited: 4
Feven Tigistu‐Sahle, Zelalem Mekuria, Abhay R. Satoskar, et al.
Frontiers in Tropical Diseases (2023) Vol. 4
Open Access | Times Cited: 4
NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike protein
Aiko Murai, Terufumi Kubo, Takayuki Ohkuri, et al.
Immunological Medicine (2024) Vol. 47, Iss. 2, pp. 93-99
Open Access | Times Cited: 1
Aiko Murai, Terufumi Kubo, Takayuki Ohkuri, et al.
Immunological Medicine (2024) Vol. 47, Iss. 2, pp. 93-99
Open Access | Times Cited: 1
SARS-CoV-2 monitoring on mink farms in Poland
Katarzyna Domańska-Blicharz, Anna Orłowska, Marcin Smreczak, et al.
Journal of Veterinary Research (2022) Vol. 66, Iss. 4, pp. 449-458
Open Access | Times Cited: 7
Katarzyna Domańska-Blicharz, Anna Orłowska, Marcin Smreczak, et al.
Journal of Veterinary Research (2022) Vol. 66, Iss. 4, pp. 449-458
Open Access | Times Cited: 7
Molecular Evolution and Epidemiological Characteristics of SARS COV-2 in (Northwestern) Poland
Karol Serwin, Andrzej Ossowski, Maria Szargut, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1295-1295
Open Access | Times Cited: 10
Karol Serwin, Andrzej Ossowski, Maria Szargut, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1295-1295
Open Access | Times Cited: 10
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
Henning Jacobsen, Monika Strengert, Henrike Maaß, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
Henning Jacobsen, Monika Strengert, Henrike Maaß, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
Prerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Cell Reports (2022) Vol. 39, Iss. 5, pp. 110754-110754
Open Access | Times Cited: 6
Prerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Cell Reports (2022) Vol. 39, Iss. 5, pp. 110754-110754
Open Access | Times Cited: 6
SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual
Gila Lustig, Yashica Ganga, Hylton Rodel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Gila Lustig, Yashica Ganga, Hylton Rodel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination
Metodi V. Stankov, Markus Hoffmann, Rodrigo Gutierrez Jauregui, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Metodi V. Stankov, Markus Hoffmann, Rodrigo Gutierrez Jauregui, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1389-1389
Open Access | Times Cited: 8
Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1389-1389
Open Access | Times Cited: 8
One Health response to SARS-CoV-2-associated risk from mink farming in British Columbia, Canada, October 2020 to October 2021
Veronic Clair, Elaine Chan, Adrianna Paiero, et al.
Canada Communicable Disease Report (2022) Vol. 48, Iss. 6, pp. 261-273
Open Access | Times Cited: 5
Veronic Clair, Elaine Chan, Adrianna Paiero, et al.
Canada Communicable Disease Report (2022) Vol. 48, Iss. 6, pp. 261-273
Open Access | Times Cited: 5
Nanomechanical analysis of SARS-CoV-2 variants and predictions of infectiousness and lethality
Yiwen Hu, Markus J. Buehler
Soft Matter (2022) Vol. 18, Iss. 31, pp. 5833-5842
Open Access | Times Cited: 5
Yiwen Hu, Markus J. Buehler
Soft Matter (2022) Vol. 18, Iss. 31, pp. 5833-5842
Open Access | Times Cited: 5
Using in vivo animal models for studying SARS-CoV-2
Camila Braz Pereira da Costa, Ana Claudia de Menezes Cruz, Julio Cesar Q Penha, et al.
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 2, pp. 121-137
Open Access | Times Cited: 6
Camila Braz Pereira da Costa, Ana Claudia de Menezes Cruz, Julio Cesar Q Penha, et al.
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 2, pp. 121-137
Open Access | Times Cited: 6
Mutations of SARS-CoV-2 variants of concern escaping Spike-specific T cells
Nina Le Bert, Anthony T. Tan, Kamini Kunasegaran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Nina Le Bert, Anthony T. Tan, Kamini Kunasegaran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Geographical distribution of SARS‐CoV ‐2 amino acids mutations and the concomitant evolution of seven distinct clades in non‐human hosts
Murali Aadhitya Magateshvaren Saras, L. Ponoop Prasad Patro, Patil Pranita Uttamrao, et al.
Zoonoses and Public Health (2022) Vol. 69, Iss. 7, pp. 816-825
Open Access | Times Cited: 4
Murali Aadhitya Magateshvaren Saras, L. Ponoop Prasad Patro, Patil Pranita Uttamrao, et al.
Zoonoses and Public Health (2022) Vol. 69, Iss. 7, pp. 816-825
Open Access | Times Cited: 4
COVID-19 in animals: A need for One Health approach
Harini Ramanujam, Kannan Palaniyandi
Indian Journal of Medical Microbiology (2022) Vol. 40, Iss. 4, pp. 485-491
Open Access | Times Cited: 4
Harini Ramanujam, Kannan Palaniyandi
Indian Journal of Medical Microbiology (2022) Vol. 40, Iss. 4, pp. 485-491
Open Access | Times Cited: 4
SARS-CoV-2 and Animals: From a Mirror Image to a Storm Warning
Francesco Pellegrini, Ahmed Hassan Omar, Canio Buonavoglia, et al.
Pathogens (2022) Vol. 11, Iss. 12, pp. 1519-1519
Open Access | Times Cited: 4
Francesco Pellegrini, Ahmed Hassan Omar, Canio Buonavoglia, et al.
Pathogens (2022) Vol. 11, Iss. 12, pp. 1519-1519
Open Access | Times Cited: 4
Enveloped Viruses: Pathogenetic Targets for Cyanobacterial Lectins
Н. Н. Беседнова, B. G. Andryukov, T. S. Zaporozhets, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2022) Vol. 67, Iss. 5-6, pp. 39-60
Open Access | Times Cited: 2
Н. Н. Беседнова, B. G. Andryukov, T. S. Zaporozhets, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2022) Vol. 67, Iss. 5-6, pp. 39-60
Open Access | Times Cited: 2
Neutralisation hierarchy of SARS-CoV-2 Variants of Concern using standardised, quantitative neutralisation assays reveals a correlation with disease severity; towards deciphering protective antibody thresholds
Diego Cantoni, Martin Mayora‐Neto, Angalee Nadesalingham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Diego Cantoni, Martin Mayora‐Neto, Angalee Nadesalingham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
